🟢 BioCryst Pharmaceuticals is trading 5% up today on technical momentum and a broad biotech rally

BioCryst Pharmaceuticals is trading up 4.9% at $9.80 as traders extend a multi-week technical uptrend.

• No fresh company-specific news or major catalysts were reported this morning, suggesting the move is driven by technical momentum and a broad bid for biotech.
• Indicators such as an overbought RSI suggest active momentum-focused buying rather than a fundamental re-rating today.
• The move aligns with broader strength in the industry, as the XBI ETF is also trading higher.